Antibiotic resistance situation of Klebsiella pneumoniae at 103 military hospital (2020 - 2022)

Thị Thu Vân Hà1, , Xuân Quảng Hoàng1, Hùng Cường Nguyễn1, Lê Vân Nguyễn1, Văn An Nguyễn1, Darong Pol2, Kimseng Hak2
1 Bộ môn - Khoa Vi sinh, Bệnh viện Quân y 103, Học viện Quân y
2 Bệnh viện Quân y Trung ương 179 Campuchia

Main Article Content

Abstract

Objectives: Determining the rate and analyzing the antibiotic resistance trend of K. pneumoniae isolated at 103 Military Hospital. Materials and methods: K. pneumoniae strains were isolated from patients treated at 103 Military Hospital from 2020 to 2022. Collect specimens and isolate bacteria according to WHO guidelines. Antibiotic susceptibility testing should be performed according to CLSI guidelines. Analyze antibiotic resistance and multi-resistance levels using Whonet2020 software; evaluate trends using the Cohran-Armitage trend test (Z, p). The recommended level of statistical significance is p < 0.05. Results: The total number of K. pneumoniae isolated was 702 strains. K. pneumoniae is more than 50% resistant to most antibiotics tested, including SXT 68.9%, NOR 68.77%; CIP 73.53%, CTX 69.97%; CAZ 69.13%; FEP 63.95%; AMC 67.58%. K. pneumoniae resistance increased over time with MEM; IMP; AN (p < 0.05). K. pneumoniae resistance to IMP from 53.99% (2020) to 65.57% (2022); MEM 56.08% (2020) to 68.38% (2022); AN 9.58% (2020) to 29.13% (2022). K. pneumoniae tended to increase MDR; XDR; and PDR throughout the study period.  There is a shift in the type of XDR bacteria replacing conventional MDR bacteria. Conclusions: K. pneumoniae has high resistance rates to most tested antibiotics. Attention should be paid to strictly implementing the management and use of antibiotics with this bacteria.

Article Details

References

1. Liu W, Chen G, Dou K, et al. Eugenol eliminates carbapenem-resistant Klebsiella pneumoniae via reactive oxygen species mechanism. Front Microbiol. 2023; 14,1090787.
2. Ai M, Pu B, Wang Y, et al. A Plasmid with conserved phage genes helps Klebsiella pneumoniae defend against the invasion of transferable DNA elements at the cost of reduced virulence. Front Microbiol. 2022; 13, 827545.
3. WHO. Bacterial priority pathogens List. 2024.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 2021.
5. Pertics BZ, Kovacs T, Schneider G. Characterization of a lytic bacteriophage and demonstration of its combined lytic effect with a K2 depolymerase on the Hypervirulent Klebsiella pneumoniae Strain 52145. Microorganisms. 2023; 11(3).
6. Vu TVD, Choisy M, Do TTN, et al. Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017. Antimicrob Resist Infect Control. 2021; 10(1)78.
7. Haque M, Sartelli M, McKimm J, et al. Health care-associated infections - an overview. Infect Drug Resist. 2018; 11:2321-2333.
8. Tanvir U, Arka C, Ameer K, et al. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. Journal of Infection and Public Health. 2021; 14:1750 -1766.
9. Nguyễn Chí Nguyễn, Trần Đỗ Hùng, Phạm Thị Ngọc Nga và CS. Tình hình đề kháng kháng sinh của Klebsiella pneumoniae được phân lập từ các mẫu bệnh phẩm tại Bệnh viện Đa khoa thành phố Cần Thơ và Bệnh viện Đa khoa Trung ương Cần Thơ năm 2021 - 2022. Tạp chí Y học Việt Nam. 2022; 517(2).
10. Garza-González E, Morfín-Otero R. A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period. PloS One. 2019; 14(3):e0209865.